CollPlant Biotechnologies Ltd. Statistics
Share Statistics
CollPlant Biotechnologies Ltd. has 11.45M shares outstanding. The number of shares has increased by 0.02% in one year.
| Shares Outstanding | 11.45M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.88M |
| Failed to Deliver (FTD) Shares | 58 |
| FTD / Avg. Volume | 0.39% |
Short Selling Information
The latest short interest is 12.07K, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 12.07K |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 0.7 |
Valuation Ratios
The PE ratio is -10.37 and the forward PE ratio is -11.31.
| PE Ratio | -10.37 |
| Forward PE | -11.31 |
| PS Ratio | 6.64 |
| Forward PS | 2.4 |
| PB Ratio | 2.57 |
| P/FCF Ratio | -19.58 |
| PEG Ratio | n/a |
Enterprise Valuation
CollPlant Biotechnologies Ltd. has an Enterprise Value (EV) of 49.02M.
| EV / Earnings | -6.98 |
| EV / Sales | 4.47 |
| EV / EBITDA | -7.65 |
| EV / EBIT | -6.53 |
| EV / FCF | -13.19 |
Financial Position
The company has a current ratio of 8.62, with a Debt / Equity ratio of 0.
| Current Ratio | 8.62 |
| Quick Ratio | 8.4 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -751.2 |
Financial Efficiency
Return on equity (ROE) is -0.25% and return on capital (ROIC) is -23.85%.
| Return on Equity (ROE) | -0.25% |
| Return on Assets (ROA) | -0.21% |
| Return on Capital (ROIC) | -23.85% |
| Revenue Per Employee | 146.12K |
| Profits Per Employee | -93.59K |
| Employee Count | 75 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.79 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -33.22% in the last 52 weeks. The beta is 0.48, so CollPlant Biotechnologies Ltd.'s price volatility has been higher than the market average.
| Beta | 0.48 |
| 52-Week Price Change | -33.22% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 4.81 |
| Relative Strength Index (RSI) | 46.53 |
| Average Volume (20 Days) | 14.83K |
Income Statement
In the last 12 months, CollPlant Biotechnologies Ltd. had revenue of 10.96M and earned -7.02M in profits. Earnings per share was -0.62.
| Revenue | 10.96M |
| Gross Profit | 8.97M |
| Operating Income | -7.51M |
| Net Income | -7.02M |
| EBITDA | -6.41M |
| EBIT | -7.51M |
| Earnings Per Share (EPS) | -0.62 |
Balance Sheet
The company has 26.67M in cash and 3.16M in debt, giving a net cash position of 23.52M.
| Cash & Cash Equivalents | 26.67M |
| Total Debt | 3.16M |
| Net Cash | 23.52M |
| Retained Earnings | -96.74M |
| Total Assets | 22.44M |
| Working Capital | 13.43M |
Cash Flow
In the last 12 months, operating cash flow was -2.76M and capital expenditures -954.00K, giving a free cash flow of -3.72M.
| Operating Cash Flow | -2.76M |
| Capital Expenditures | -954.00K |
| Free Cash Flow | -3.72M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 81.83%, with operating and profit margins of -68.55% and -64.05%.
| Gross Margin | 81.83% |
| Operating Margin | -68.55% |
| Pretax Margin | -64.05% |
| Profit Margin | -64.05% |
| EBITDA Margin | -58.49% |
| EBIT Margin | -68.55% |
| FCF Margin | -33.92% |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -16.15% |
| FCF Yield | -8.44% |
Analyst Forecast
The average price target for CLGN is $14, which is 264.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 264.6% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Dec 1, 2016. It was a backward split with a ratio of 2:3.
| Last Split Date | Dec 1, 2016 |
| Split Type | backward |
| Split Ratio | 2:3 |
Scores
| Altman Z-Score | -3.29 |
| Piotroski F-Score | 1 |